Genomic instability and telomere fusion of canine osteosarcoma cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Maeda, Junko ^a   Yurkon, Charles R ^a   Fujisawa, Hiroshi ^a   Kaneko, Masami ^a   Genet, Stefan C ^a   Roybal, Erica J ^a   Rota, Garrett W ^a   Saffer, Ethan R ^a   Rose, Barbara J ^a   Hanneman, William H ^a   Thamm, Douglas H ^a   Kato, Takamitsu A ^a  

^a Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HISTONE GAMMA H2AX; HISTONE H2AX; PROTEIN KINASE C; TELOMERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL FUSION; CELL PROLIFERATION; CELL SURVIVAL; CHROMOSOME; CHROMOSOME ABERRATION; CHROMOSOME DOUBLING; CHROMOSOME NUMBER; CONTROLLED STUDY; CYTOGENETICS; DNA CONTENT; DOG; ENZYME ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE FREQUENCY; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; INTERPHASE; NONHUMAN; NUCLEIC ACID PROBE; OSTEOSARCOMA; PHENOTYPE; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TELOMERE;

ANIMALS; CHROMOSOMES; DOGS; GENOMIC INSTABILITY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; OSTEOSARCOMA; TELOMERE;

EID: 84865096538     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043355     Document Type: Article

References (54)

1. Marina N, Gebhardt M, Teot L, Gorlick R, (2004) Biology and therapeutic advances for pediatric osteosarcoma. Oncologist 9: 422-441.
2. Chun R, de Lorimier LP (2003) Update on the biology and management of canine osteosarcoma. Vet Clin North Am Small Anim Pract 33: 491-516, vi.
3. Jaffe N, (2009) Osteosarcoma: review of the past, impact on the future. The American experience. Cancer Treat Res 152: 239-262.
4. Mueller F, Fuchs B, Kaser-Hotz B, (2007) Comparative biology of human and canine osteosarcoma. Anticancer Res 27: 155-164.
5. Dernell WS, Ehrhardt NP, Straw RC, Vail DM (2007) Tumors of the skeletal system. In: Withrow SJ, Vail DM, editors. St Louis, MO: Saunders. 540-582.
6. Vail DM, MacEwen EG, (2000) Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 18: 781-792.
7. Withrow SJ, Powers BE, Straw RC, Wilkins RM (1991) Comparative aspects of osteosarcoma. Dog versus man. Clin Orthop Relat Res: 159-168.
8. Hansen K, Khanna C, (2004) Spontaneous and genetically engineered animal models; use in preclinical cancer drug development. Eur J Cancer 40: 858-880.
9. Paoloni M, Davis S, Lana S, Withrow S, Meltzer P, et al. (2005) Comparative gene expression analysis of canine and human osteosarcoma. At: 25th Annual Conference of the Veterinary Cancer Society. Hountington Beach, California. 54.
10. Khanna C, Lindblad-Toh K, Vail DM, et al. (2006) The dog as a caner model. Nat Biotechnol 24: 1065.
11. Albertson DG, Collins C, McCormick F, Gray JW, (2003) Chromosome aberrations in solid tumors. Nat Genet 34: 369-376.
12. Breen M, Bullerdiek J, Langford CF, (1999) The DAPI banded karyotype of the domestic dog (Canis familiaris) generated using chromosome-specific paint probes. Chromosome Res 7: 401-406.
13. Breen M, (2008) Canine cytogenetics-from band to basepair. Cytogenet Genome Res 120: 50-60.
14. Taylor N, Shifrine M, Wolf HG, Trommershausen-Smith A, (1975) Canine osteosarcoma karyotypes from an original tumor, its metastasis, and tumor cells in tissue culture. Transplant Proc 7: 485-493.
15. Yuen KW, Montpetit B, Hieter P, (2005) The kinetochore and cancer: what's the connection? Curr Opin Cell Biol 17: 576-582.
16. Storchova Z, Pellman D, (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat Rev Mol Cell Biol 5: 45-54.
17. Scheel C, Schaefer KL, Jauch A, Keller M, Wai D, et al. (2001) Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 20: 3835-3844.
18. Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, et al. (2003) Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res 63: 1759-1763.
19. Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, et al. (2004) Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 22: 3790-3797.
20. Biller BJ, Kitchell BE, Cadile CD, (1998) Evaluation of an assay for detecting telomerase activity in neoplastic tissues of dogs. Am J Vet Res 59: 1526-1529.
21. Yazawa M, Okuda M, Setoguchi A, Nishimura R, Sasaki N, et al. (1999) Measurement of telomerase activity in dog tumors. J Vet Med Sci 61: 1125-1129.
22. Kow K, Thamm DH, Terry J, Grunerud K, Bailey SM, et al. (2008) Impact of telomerase status on canine osteosarcoma patients. J Vet Intern Med 22: 1366-1372.
23. Campisi J, (1997) The biology of replicative senescence. Eur J Cancer 33: 703-709.
24. Shay JW, Bacchetti S, (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
25. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
26. Reddel RR, Bryan TM, Colgin LM, Perrem KT, Yeager TR, (2001) Alternative lengthening of telomeres in human cells. Radiat Res 155: 194-200.
27. Blackburn EH, (1991) Structure and function of telomeres. Nature 350: 569-573.
28. Gisselsson D, Jonson T, Petersen A, Strombeck B, Dal Cin P, et al. (2001) Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors. Proc Natl Acad Sci U S A 98: 12683-12688.
29. Bailey SM, Murnane JP, (2006) Telomeres, chromosome instability and cancer. Nucleic Acids Res 34: 2408-2417.
30. Desmaze C, Soria JC, Freulet-Marriere MA, Mathieu N, Sabatier L, (2003) Telomere-driven genomic instability in cancer cells. Cancer Lett 194: 173-182.
31. Baird DM, (2008) Mechanisms of telomeric instability. Cytogenet Genome Res 122: 308-314.
32. Bailey SM, Meyne J, Chen DJ, Kurimasa A, Li GC, et al. (1999) DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A 96: 14899-14904.
33. Williams ES, Klingler R, Ponnaiya B, Hardt T, Schrock E, et al. (2009) Telomere dysfunction and DNA-PKcs deficiency: characterization and consequence. Cancer Res 69: 2100-2107.
34. Reimann N, Rogalla P, Kazmierczak B, Bonk U, Nolte I, et al. (1994) Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions. Cytogenet Cell Genet 67: 81-85.
35. Thomas R, Wang HJ, Tsai PC, Langford CF, Fosmire SP, et al. (2009) Influence of genetic background on tumor karyotypes: evidence for breed-associated cytogenetic aberrations in canine appendicular osteosarcoma. Chromosome Res 17: 365-377.
36. Mayr B, Eschborn U, Loupal G, Schleger W, (1991) Characterisation of complex karyotype changes in two canine bone tumours. Res Vet Sci 51: 341-343.
37. Bayani J, Zielenska M, Pandita A, Al-Romaih K, Karaskova J, et al. (2003) Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer 36: 7-16.
38. Fitzpatrick CL, Farese JP, Milner RJ, Salute ME, Rajon DA, et al. (2008) Intrinsic radiosensitivity and repair of sublethal radiation-induced damage in canine osteosarcoma cell lines. Am J Vet Res 69: 1197-1202.
39. Schwartz JL, Murnane J, Weichselbaum RR, (1999) The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines. Br J Cancer 79: 744-747.
40. Legare ME, Bush J, Ashley AK, Kato T, Hanneman WH, (2011) Cellular and phenotypic characterization of canine osteosarcoma cell lines. J Cancer 2: 262-270.
41. Murnane JP, (2012) Telomere dysfunction and chromosome instability. Mutation Research 730: 28-36.
42. Silva AG, Graves HA, Guffei A, Ricca TI, Mortara RA, et al. (2010) Telomere-centromere-driven genomic instability contributes to karyotype evolution in a mouse model of melanoma. Neoplasia 12: 11-19.
43. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM, (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273: 5858-5868.
44. Nakamura AJ, Redon CE, Bonner WM, Sedelnikova OA, (2009) Telomere-dependent and telomere-independent origins of endogenous DNA damage in tumor cells. Aging (Albany NY) 1: 212-218.
45. Hao LY, Strong MA, Greider CW, (2004) Phosphorylation of H2AX at short telomeres in T cells and fibroblasts. J Biol Chem 279: 45148-45154.
46. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, et al. (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194-198.
47. Verdun RE, Karlseder J, (2007) Replication and protection of telomeres. Nature 447: 924-931.
48. van Steensel B, Smogorzewska A, de Lange T, (1998) TRF2 protects human telomeres from end-to-end fusions. Cell 92: 401-413.
49. Sarthy J, Bae NS, Scrafford J, Baumann P, (2009) Human RAP1 inhibits non-homologous end joining at telomeres. EMBO J 28: 3390-3399.
50. Hockemeyer D, Daniels JP, Takai H, de Lange T, (2006) Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell 126: 63-77.
51. Mayr B, Kramberger-Kaplan E, Loupal G, Schleger W, (1992) Analysis of complex cytogenetic alterations in three canine mammary sarcomas. Res Vet Sci 53: 205-211.
52. Mayr B, Reifinger M, Weissenbock H, Schleger W, Eisenmenger E, (1994) Cytogenetic analyses of four solid tumours in dogs. Res Vet Sci 57: 88-95.
53. Stone DM, Jacky PB, Prieur DJ, (1991) Cytogenetic evaluation of four canine mast cell tumors. Cancer Genet Cytogenet 53: 105-112.
54. Fujinaga T, Yamashita M, Yoshida MC, Mizuno S, Okamoto Y, et al. (1989) Chromosome analysis of canine transmissible sarcoma cells. Zentralbl Veterinarmed A 36: 481-489.